mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.002 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |